application): In this Phase I grant application, the researchers propose to develop the synthesis of a series of inositolphospholipids, including 1d-1-(1-fattyacyl'- 2-fattyacyl''-sn-glycero-3-phospho)-myo-inositols (phosphatidylinositols) and analogues. In eukaryotic cells, these compounds function as structural components of membranes and protein anchors, and are metabolic precursors of intracellular messengers. Practical approaches for the economical synthesis of these compounds are not available. During Phase I, the applicants will develop laboratory scale approaches, potentially adaptable for the economical larger scale preparation of phosphatidylinositols and analogues.

Proposed Commercial Applications

The methods will be used for commercial production and marketing of phosphatidylinositols for biomedical applications. ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43GM059550-01
Application #
2869892
Study Section
Special Emphasis Panel (ZRG1-SSS-Z (01))
Project Start
1999-06-01
Project End
1999-11-30
Budget Start
1999-06-01
Budget End
1999-11-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Nutrimed Biotech
Department
Type
DUNS #
City
Ithaca
State
NY
Country
United States
Zip Code
14850